Longevity Biotech Fellowship
The LBF Fellowship Awards recognize scientists, founders, engineers, and organizers pushing the longevity biotech roadmap from idea to institution.
Meet the first publicly announced LBF8 Fellowship Award recipients, working across therapeutics, replacement biology, AI-enabled discovery, gene editing, cryopreservation, and the systems needed to make ambitious longevity projects real.
OsteoCure Therapeutics
Hunter Newman, PhD, is Co-Founder and CEO of OsteoCure Therapeutics, a Duke University spinout developing adenosine-based therapies to rebuild bone, prevent fractures, and extend healthy longevity by preserving skeletal health.
Genome and transcriptome engineer; former Senior Scientist, Arc Institute
Dhruva is a platform builder who has developed DNA and RNA-editing technologies. He has engineered large-scale changes to the human genome at the Arc Institute. At UC San Diego, he built an RNA-editing platform that became Shape Therapeutics.
Harvard Medical School postdoctoral work; MIT PhD work on neurobiology of aging
Alex is a Harvard Medical School postdoc developing transcription-factor gene therapies to treat brain aging.
Founder and CEO, Fidra Therapeutics
Harsh Vaidya is founder and CEO of Fidra Therapeutics, developing a multi-pathway therapy to prevent inflammaging and aging-related disease.
Principal, JLS Fund; biotech operator and investor
Brendan Hussey, PhD is a synthetic biologist and JLS Fund principal who has worked across venture creation, biotech operating roles, investment banking, and life-science investing.
Professor, UMass Amherst; co-founder, ReGENE
Sasha Suvorov is a UMass Amherst professor and co-founder of ReGENE translating mechanistic biogerontology into rejuvenation biotech and studying how aging and environmental stress reshape the sperm epigenome.
Postdoctoral researcher, Helmholtz Munich
Harish is a postdoctoral researcher at Helmholtz Munich working at the intersection of immunology, aging, and lung biology.
Bioengineer; cell and tissue engineering systems
Deniz is a bioengineer who builds and scales systems for cell and tissue engineering, now exploring what they can unlock for longevity.
Founder, Sundial Therapeutics
Nakoa Israel Po is founder of Sundial Therapeutics, engineering placental-derived stem cells into non-surgical cell therapies to replace damaged brain tissue.
Co-founder and CTO, Eclypsium
Alex is a security engineer and co-founder and CTO of Eclypsium. Previously, he was a Senior Security Researcher at Intel, working on platform and hardware security.
Researcher, Corperial Technologies; University of Pittsburgh
Robin is a computational bioengineer working on perfusion technology for liver and building communities around rejuvenation research and political advocacy.
Co-founder, Atlas Discovery
Sanjukta is co-founder of Atlas Discovery, building foundational models of patient biology that predict clinical-trial outcomes to inform trial design, rescue failed trials, and repurpose drugs.
Co-founder and CTO, ProviGen
Lucas is co-founder and CTO of ProviGen, building physical-AI software with closed-loop optimization for robotic life science laboratories and biomanufacturing infrastructure.
Cornell University PhD candidate
Herbert is a Cornell PhD candidate developing new senolytics and tools to chemically profile senescent cells and aging tissues.
Gene-editing and delivery researcher
Jonathan Kittel is a gene-editing and delivery researcher who has developed nanoparticle systems for gene editing in rat brains, with a focus on making replacement-cell therapies more reliable. He also studies sterile inflammation and retroelements.
Founder and CEO, NieuMind
Zak Moktar is founder and CEO of NieuMind, developing purpose-built surgical instruments to enable brain-tissue replacement, first in large-animal models.
Co-founder and CTO, CasNx
Santosh is co-founder and CTO of CasNx, which uses CRISPR to edit donor organs during ex vivo perfusion before transplant, aiming to reduce post-transplant complications and extend graft life.
University of British Columbia
Yoonha is an engineering physicist from the University of British Columbia, previously working on cryogenic systems at D-Wave and battery engineering at Tesla. He is currently exploring reversible cryopreservation to combat aging.
Griffin Labs
Andrei is founder of Griffin Labs, developing AI systems for digital twins of human biology, optimal experiment design, and closed-loop high-throughput biomedical discovery.
Postdoctoral Research Fellow, Dana-Farber Cancer Institute and Harvard Medical School
Nathan is a postdoctoral fellow at Dana-Farber and Harvard Medical School, building machine-learning models of cellular responses to perturbations and the genetic architecture of disease.
Forward Deployed Engineer, Palantir Technologies
Jane Mo is a forward-deployed engineer at Palantir. She studied computer science at Duke, with additional coursework in biology, and has experience in health research and biotech community-building.